Get the Stockscreener App
1.0999
1.84%
0.0199
Therapeuticsmd Inc stock is traded at $1.0999, with a volume of 21,561.
It is up +1.84% in the last 24 hours and down -3.52% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.08
Open:
$1.07
24h Volume:
21,561
Relative Volume:
0.57
Market Cap:
$12.73M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.0753
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-5.98%
1M Performance:
-3.52%
6M Performance:
-15.39%
1Y Performance:
-37.15%
1-Day Range:
$1.055
$1.10
1-Week Range:
$1.055
$1.18
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.0999 | 13.19M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Custom watchlist performance reports with TherapeuticsMD Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
TherapeuticsMD Swings to Profit in Q2 - Mitrade
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
Quantitative breakdown of TherapeuticsMD Inc. recent moveAnalyst Downgrade & Verified Momentum Stock Ideas - Newser
What MACD signals say about TherapeuticsMD Inc.Take Profit & Risk Adjusted Buy and Sell Alerts - Newser
Short interest data insights for TherapeuticsMD Inc.Weekly Trading Summary & Consistent Return Investment Signals - Newser
Analyzing drawdowns of TherapeuticsMD Inc. with statistical toolsJuly 2025 Technicals & Safe Entry Trade Reports - Newser
Has TherapeuticsMD Inc. formed a bullish divergenceWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Is TherapeuticsMD Inc. meeting your algorithmic filter criteriaQuarterly Trade Summary & Precise Swing Trade Alerts - Newser
Will TherapeuticsMD Inc. continue its uptrendPortfolio Update Report & Weekly Setup with ROI Potential - Newser
Using data tools to time your TherapeuticsMD Inc. exitWeekly Gains Summary & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-19 16:42:31 - Newser
Published on: 2025-08-19 14:42:22 - Newser
What to do if you’re stuck in TherapeuticsMD Inc.2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Tick level data insight on TherapeuticsMD Inc. volatilityJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryMarket Activity Summary & Daily Momentum Trading Reports - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersEarnings Miss & Smart Money Movement Tracker - Newser
Using fundamentals and technicals on TherapeuticsMD Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
TherapeuticsMD Inc. stock trend forecastJuly 2025 Patterns & Risk Controlled Daily Plans - Newser
Leading vs lagging indicators on TherapeuticsMD Inc. performancePortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Can volume confirm reversal in TherapeuticsMD Inc.July 2025 Closing Moves & Safe Entry Point Identification - Newser
Is it time to cut losses on TherapeuticsMD Inc.2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
How TherapeuticsMD Inc. stock performs during market volatilityJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningSell Signal & AI Enhanced Trade Execution Alerts - Newser
Market reaction to TherapeuticsMD Inc.’s recent newsJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutGap Down & Long-Term Safe Investment Plans - Newser
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Therapeuticsmd Inc Stock (TXMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):